Holen Sie sich die Stockscreener-App
24.54
3.16%
-0.80
Handel nachbörslich:
24.62
0.08
+0.33%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
3 Value Stocks Worth Buying in Current Market Conditions - Investing.com
Pfizer Crosses Above 7% Yield Territory - Forbes
Pfizer wins label expansion for RSV shot in EU (PFE:NYSE) - Seeking Alpha
Pfizer, Merck Lose Appeal To Patent Cancer Drug Dosage - Law360
Pfizer (NYSE:PFE) Expands RSV Vaccine Use In Europe Amid 3% Share Price Dip - simplywall.st
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump - TipRanks
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Global markets live: Tesla, Chevron, Pfizer, Michelin, Toyota… - MarketScreener
Injectable Drugs Market to Witness Massive Growth by 2032 | - openPR.com
Is Pfizer Inc. (PFE) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Yahoo Finance
Flagship Pioneering Agreement With Pioneering Medicines & Pfizer To Discover Potential Novel, Selective Inhibitors For Autoimmune Disease - MarketScreener
Former Pfizer CSO Mikael Dolsten on writing his next chapter, embracing AI and asking the ‘big questions’ - PharmaVoice
Pfizer: extension of indication for RSV vaccine - MarketScreener
Major Breakthrough: Pfizer Teams With Flagship to Develop AI-Driven Autoimmune Treatments - Stock Titan
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK - Yahoo Finance
Pfizer Says European Commission Approves Abrysvo RSV Vaccine for Adults - MarketScreener
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease - Reuters
to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease - Business Wire
Pfizer COVID-19 Bombshell Puts 2020 Election Into Context - The Daily Signal
Inflammatory Myositis Market on Track for Major Expansion by 2034, According to DelveInsight | CSL Behring, Argenx, Priovant Therapeutics/Roivant, Alexion Pharma, Pfizer, Horizon Therapeutics - Barchart.com
Is Trending Stock Pfizer Inc. (PFE) a Buy Now? - Yahoo Finance
Pfizer: Looks Better Than Most, But I Can't Eat Relative Returns - Seeking Alpha
Top 12 Pharma Companies: Pfizer Tops The Leaderboard Again - insights.citeline.com
Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows - Insider Monkey
Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns - Seeking Alpha
What Does the Market Think About Pfizer? - Benzinga
Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (Rating Upgrade) - Seeking Alpha
Minoxidil Market Set to Witness Significant Growth by 2025-2032 - openPR
Pfizer leader who launched Covid vaccine gives small pharma a try - The Business Journals
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History” - markets.businessinsider.com
UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection | Newswise - Newswise
Pfizer: Value Play Or Past Its Prime? - Barchart
Pfizer: Value Play or Past Its Prime? - The Globe and Mail
Pfizer Tops Pharma Tax Avoidance, Senate Dems Say - Law360
US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports - Reuters
Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator - Seeking Alpha
Sector Update: Health Care - Marketscreener.com
Pfizer's Bold Tax Maneuver Sparks Controversy - Finimize
Is Pfizer Stock A Sell With A Looming First-Quarter Slowdown? - Investor's Business Daily
Pfizer Avoided Billions in Taxes on Sales, Democrats Say (2) - Bloomberg Tax
Living with Colon Cancer: A Pfizer Colleague’s Story - Pfizer
May 9th Options Now Available For Pfizer (PFE) - Nasdaq
GSK accuses Pfizer of delaying Covid vaccine result until after US election - Yahoo
Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals? - Yahoo Finance
Why Pfizer Is My Largest Healthcare Position - MSN
Citi maintains Pfizer stock Neutral with $27 target amid probe By Investing.com - Investing.com Australia
Citi maintains Pfizer stock Neutral with $27 target amid probe - Investing.com
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report - New York Post
Pfizer Stock Slips After Report on Vaccine Timing Probe - WSJ
Exclusive | U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine - WSJ
Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers - GuruFocus.com
Here's Why Pfizer (PFE) Fell More Than Broader Market - Yahoo Finance
Pfizer Shares Are Down Today: What's Going On? - Benzinga
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):